About Us

Dyne was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.

Because together, we are stronger.

Our leadership team

Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities:

RECEPTOR
BIOLOGY

RECEPTOR
BIOLOGY

MUSCLE
BIOLOGY

MUSCLE
BIOLOGY

ANTIBODY
ENGINEERING

ANTIBODY
ENGINEERING

OLIGONUCLEOTIDE
DESIGN

OLIGONUCLEOTIDE
DESIGN

DRUG DISCOVERY &
DEVELOPMENT

DRUG DISCOVERY &
DEVELOPMENT

RARE MUSCLE
DISEASES

RARE MUSCLE
DISEASES

LINKER
CHEMISTRY

LINKER
CHEMISTRY

CLINICAL
DEVELOPMENT

CLINICAL
DEVELOPMENT

LEADERSHIP TEAM

josh brumm dyne site 1
Romesh Subramanian
jonathan mcneil headshot
Joanne Bryce headshot
Bruce Wentworth headshot
Mo Qatanani

Board of directors

Scientific Advisory Board

INVESTORS

We are supported by a group of leading investors who share our pioneering mission.

  • Atlas Venture logo
  • Forbion logo
  • MPM Logo